Facts and figures
| Headquarter | Denmark |
International | Production facilities in seven countries, affiliates or offices in 78 countries |
Workforce | 20,725 full-time employees end 2004. The full-time equivalent end 2004 was 20,285 |
Approximately 59% of employees are located in Denmark, 41% in the rest of the world.
15% within research and development
38% in production and production administration
28% in international sales and marketing
19% in administration
| Product areas | Diabetes care Haemostasis management (NovoSeven®) Growth hormone therapy Hormone replacement therapy (HRT) |
Sales*: 29,031
Sales by business segment* | Diabetes care 20,533 Biopharmaceuticals 8,498 |
Turnover by region* | Europe 12,411 Japan & Oceania 4,298 North America 7,478 International Operations 4,844 |
* million Danish kroner, full year 2004
